Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted Sort descending
Job Title Site Location Division Business Functional Area Date Posted Sort descending
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Quality Assurance Specialist Murcia Spain Operations Innovative Medicines Quality Oct 16, 2024
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Feasibility Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Oct 16, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
Sales Representative (w/m/d), TA: Immunologie, Gebiet: Brandenburg Brandenburg (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Netzwerk Manager (m/w/d), Prostate Cancer, Saarland und Rheinland-Pfalz Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Logistics Analyst Santo Amaro Brazil Operations Innovative Medicines Technical Operations Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
县域主任(主管) Sanmenxia (Henan Province) China International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Zhengzhou (Henan Province) China International Innovative Medicines Sales Oct 16, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality Oct 17, 2024
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Quality Oct 17, 2024
Lead, QSRC (Quality System Regulatory Compliance) Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 17, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Oct 17, 2024
Medical Science Liaison - Solid Tumors Bucuresti Romania International Innovative Medicines Research & Development Oct 17, 2024
Ekspert upravljanja kakovosti za proces proizvodnje bioloških učinkovin (m/ž/d) / QA expert for the production process of biological agents (m/f/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Manager, Analytical Product Services Hyderabad (Office) India Operations CTS Marketing Oct 17, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 17, 2024
Manager, Analytical Product Services Hyderabad (Office) India Operations CTS Marketing Oct 17, 2024
Skladiščnik (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Oct 17, 2024
Sr Principal Observability Engineer Hyderabad (Office) India Biomedical Research Pharma Research Technology Transformation Oct 17, 2024
Country Patient Safety Head - France Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Oct 17, 2024
Sales Representative (d/w/m), Rheumatologie,Gebiet: Südhessen Hessen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 17, 2024
Senior Expert Technical Development- Drug Product Project Lead East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Vendor Alliance Lead Associate Director (Remote) East Hanover USA Development Innovative Medicines Research & Development Oct 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Oct 17, 2024
Senior Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 17, 2024
Production Technician I Millburn USA Operations Innovative Medicines Technical Operations Oct 17, 2024
Sr. Specialist DDIT ISC Detection & Response Hyderabad (Office) India Operations CTS Technology Transformation Oct 17, 2024
Laboratorijski analitik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
Specialist kontrole kakovosti (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
AS&T specialist (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 17, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 17, 2024
Global Program Safety Lead - Immunology Basel (City) Switzerland Development Innovative Medicines Research & Development Oct 17, 2024
Global Program Safety Lead - Immunology London (The Westworks) United Kingdom Development Sandoz Research & Development Oct 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only